Based on interview and record review, the facility failed to ensure an admission assessment accurately reflects the resident status for two (Resident (R) 65 and R49) of 18 residents sampled. Review of the resident's Minimum Data Set (MDS) documented R65 was coded as being on an anticoagulant, but R65 was on an antiplatelet. Also, R49 was coded and having received insulin, but did not actually receive insulin. Findings include: 1) On 07/14/26 at 12:59 PM, conducted a review R65's Electronic Health Record (EHR). Review of R65's admission MDS with an Assessment Reference Date (ARD) of 06/22/26, Section N, N0415. High-Risk Drug Classes: Use and Indication, E. Anticoagulant was marked yes, indicating the resident was receiving anticoagulant medication. …
F641 citations in Hawaii
Accuracy of assessments · Resident Assessment and Care Planning Deficiencies
Ensure each resident receives an accurate assessment.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
Hawaii cites F641 more often than its own record predicts
1.47 times the share F641 takes of citations nationally.
Of every deficiency written in Hawaii in 2025, this is the portion that was F641.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Hawaii surveyors wrote
F641 findings written in Hawaii, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
The short window
Recent years
| Year | Share of Hawaii citations | vs expected |
|---|---|---|
| 2023 | 2.11% | 1.24× |
| 2024 | 2.21% | 1.31× |
| 2025 | 2.71% | 1.47× |
Shares of citations, not counts: earlier years hold fewer inspections.
What else Hawaii surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction